Xtant Medical

Xtant Medical Announces Results of Special Meeting of Stockholders

Approval of the issuance of new shares of common stock, as required by the NYSE American. Approval of an amendment to its certificate of incorporation, enabling its previously announced 1:12 reverse stock split. Approval of new directors to serve on its board. BELGRADE, Mont., Feb. 13, 2018 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the results of its Special Meeting of Stockholders held on February 13, 2018 (the “Special Meeting”).  As a result of the approval of all proposals at the Special Meeting, Xtant expects that it will be able to fully execute …